Fetal Sheep Serum Contains a High Molecular Weight Insulin-Like Growth Factor (IGF) Binding Protein that Is Acid Stable and Specific for IGF-II*
- 1 December 1987
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 121 (6), 1975-1984
- https://doi.org/10.1210/endo-121-6-1975
Abstract
We have used radiolabeled ovine insulin-like growth factor II (oIGF-II) and human IGF-I (hIGF-I) to investigate the nature of the IGF binding protein in fetal sheep serum. Incubation of fetal sheep serum with [125I]oIGF-II, followed by chromatography on Fractogel TSK HW55(S), revealed the presence of two major binding protein species, a lower molecular weight binding protein (apparent mol wt .apprx. 60,000) and a much higher molecular weight binding protein (apparent mol wt .apprx. 500,000). Only the lower molecular weight binding protein complex was seen in serum from adult nonpregnant sheep. The lower molecular weight binding protein in fetal and adult sheep serum bound both [125I]oIGF-II and [125I]hIGF-I, both of which could be displaced by unlabeled oIGF-II or hIGF-I. However, the very high molecular weight binding protein bound only [125I]oIGF-II, and this could only be displaced by unlabeled oIGF-II. The very high molecular weight binding protein appears to bind approximately 40% of the endogenous of oIGF-II. We have purified the very high molecular weight binding protein from fetal sheep serum using anion exchange, Concanavalin A Sepharose, and hydrophobic interaction chromatography. The purified binding protein preparation did not contain any lower molecular weight binding protein and did not bind [125I]hIGF-I. In addition, this binding protein was stable at pH 3.2 for 1 h. Thus, fetal sheep serum contains a very high molecular weight IGF binding glycoprotein that is acid stable and specific for IGF-II.This publication has 18 references indexed in Scilit:
- Developmental Pattern of a Serum Binding Protein for Multiplication Stimulating Activity in the RatJournal of Clinical Investigation, 1982
- Measurement of Somatomedin-Related Peptides in Fetal, Neonatal, and Maternal Rat Serum by Insulin-Like Growth Factor (IGF) I Radioimmunoassay, IGF-II Radioreceptor Assay (RRA), and Multiplication- Stimulating Activity RRA after Acid-Ethanol Extraction*Endocrinology, 1982
- A Radioimmunoassay for Insulin-like Growth Factor II Specific for the C-Peptide Region*Journal of Clinical Endocrinology & Metabolism, 1982
- The Growth Hormone Dependence of a Somatomedin-Binding Protein in Human Serum*Journal of Clinical Endocrinology & Metabolism, 1981
- Inhibition of Access of Bound Somatomedin to Membrane Receptor and Immunobinding Sites: A Comparison of Radioreceptor and Radioimmunoassay of Somatomedin in Native and Acid-Ethanol-Extracted Serum*Journal of Clinical Endocrinology & Metabolism, 1980
- CHANGES IN THE CIRCULATING FORM OF SERUM SOMATOMEDIN-C DURING FETAL LIFEJournal of Clinical Endocrinology & Metabolism, 1980
- The Somatomedin C Binding Protein: Evidence for a Heterologous Subunit Structure*Journal of Clinical Endocrinology & Metabolism, 1980
- Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum.Proceedings of the National Academy of Sciences, 1980
- The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.Journal of Biological Chemistry, 1978
- EFFECTS OF ELECTROCOAGULATION OF THE FOETAL LAMB HYPOPHYSIS ON GROWTH AND DEVELOPMENTJournal of Endocrinology, 1968